Boussard & Gavaudan Investment Management’s 1Life Healthcare ONEM Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-317,112	Closed	-$5.3M	–	148
2022 Q4	$5.3M	Buy	+317,112	New	+$5.36M	0.59%	49

Boussard & Gavaudan Investment Management's ONEM Position: Q1 2023 in Review

Boussard & Gavaudan Investment Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 317,112 shares — an estimated $5.3M sold.

Boussard & Gavaudan Investment Management first reported a position in ONEM in Q4 2022 and held it in 1 quarter. The position peaked at $5.3M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Boussard & Gavaudan Investment Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 317,112 1Life Healthcare shares in Q1 2023, an estimated $5.3M.
Boussard & Gavaudan Investment Management first reported a position in 1Life Healthcare in Q4 2022 and held it in 1 quarter.
Boussard & Gavaudan Investment Management's 1Life Healthcare position peaked at $5.3M in Q4 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2023, filed 11 May 2023.